Nvision Biomedical Technologies
PrivateLast Round
Series B
May 13, 2026
Est. Valuation
$250M
Total Funding Raised
$55.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nvision Biomedical Technologies is a medical devices company that provides surgeons with implants paired with instrumentation and biologics to simplify and improve surgery procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, 3D Printing, Advanced Materials, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nvision Biomedical Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nvision Biomedical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2026 | ||||
| Debt | Apr 28, 2020 | ||||
| Seed | Sep 18, 2017 |
Nvision Biomedical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Entrée Capital | Series B |
| European Investment Bank Group | Series B |
| CDP Venture Capital SGR | Series B |
| JPMorgan Chase & Co. | Debt |
| Playground Global | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$55M round led by Abbott Laboratories.
- Jul 20, 2025
Grew 16% QoQ, from 19 to 22 employees.
Nvision Biomedical Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nvision Biomedical Technologies's valuation, stock price, and market status.